Evidence map›Paper›PMID 28432523›Full record

ArticleClinical rheumatology2017

Hypothesis-free analyses from a large psoriatic arthritis cohort support merger to consolidated peripheral arthritis definition without subtyping.

Daniel Stekhoven, Almut Scherer, Michael J Nissen, Véronique Grobéty, Nikhil Yawalkar, Peter M Villiger, Burkhard Möller, Swiss Clinical Quality Management for Rheumatic Diseases

Open access · hybridAbstract read
In one paragraph

Article in Clinical rheumatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Daniel StekhovenSCQM Statistics Group, Zurich, Switzerland.
Almut SchererSCQM Statistics Group, Zurich, Switzerland.
Michael J NissenDepartment of Rheumatology, University Hospital Geneva, Geneva, Switzerland.
Véronique GrobétyDepartment of Rheumatology, Immunology and Allergology, Inselspital, University Hospital Bern, Freiburgstraße, 3010, Bern, Switzerland.
Nikhil YawalkarDepartment of Dermatology, Inselspital, University Hospital Bern, Bern, Switzerland.
Peter M VilligerDepartment of Rheumatology, Immunology and Allergology, Inselspital, University Hospital Bern, Freiburgstraße, 3010, Bern, Switzerland.
Burkhard MöllerDepartment of Rheumatology, Immunology and Allergology, Inselspital, University Hospital Bern, Freiburgstraße, 3010, Bern, Switzerland. burkhard.moeller@insel.ch.ORCID http://orcid.org/0000-0001-8769-6167
Swiss Clinical Quality Management for Rheumatic Diseases
University Hospital of Bern · CHETH Zurich · CHSCQM Foundation · CHUniversity Hospital of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Current ClASsification criteria for Psoriatic ARthritis classification criteria for psoriatic arthritis (PsA) provide a preliminary definition of inflammatory articular disease. This study aimed to further characterize PsA peripheral arthritis using purely data-driven approaches for the affected joint distribution pattern. PsA patients from the Swiss Clinical Quality Management in Rheumatic Diseases (SCQM) database were clustered according to similarities in 66 swollen and in 68 tender joints. Clusters were compared in terms of other disease characteristics and studied for coincidence with traditional PsA subtypes, stability over time and treatment response upon first tumour necrosis factor alpha (TNF-α) therapy. Clustering of 957 patients resulted in an oligoarticular, a polyarticular hand dominated, a polyarticular foot dominated and a fourth cluster which was characterized by polyarticular involvement of the hands and feet. Of the traditional PsA subtypes, only a non-PsA-specific oligoarticular joint involvement pattern was retrieved by clustering. When comparing clusters in other disease manifestations, only minor and clinically probably irrelevant differences occurred. Over time, clusters were more robust than traditional PsA subtypes. Patients in different joint clusters had similar response rates upon first anti-TNF-α therapy, and minimal disease activity was achieved in 56% of 285 patients, irrespective of cluster membership. Hypothesis-free approaches to group PsA patients yield clusters with improved consistency, but without clinically important differences. Taken together, the current peripheral arthritis definition by GRAPPA without further specification into subtypes is strongly supported by the data.

Indexed as

AdultAntirheumatic AgentsArthritis, PsoriaticCohort StudiesDisease ProgressionFemaleFootHandHumansLogistic ModelsMaleMiddle AgedSeverity of Illness IndexSwitzerlandTreatment OutcomeTumor Necrosis Factor-alphaAntirheumatic AgentsTumor Necrosis Factor-alphaAnti-TNFDisease activityPeripheral arthritisPsoriatic arthritisSubtypes

Identifiers

PMID28432523
PMCPMC5554477
OpenAlexW2606771170

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.